FAQ/Help |
Calendar |
Search |
Today's Posts |
02-08-2011, 08:05 PM | #1 | ||
|
|||
Member
|
Chelsea Therapeutics Announces Interim Results and Plans to Modify Study 306 to Focus on Reduction in Falls Associated With Neurogenic Orthostatic Hypotension
See NT PD Clinical Trials....click above to go to there |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
NORTHERA™ (droxidopa) Phase III, Chelsea Therapeutics Inter | Parkinson's Disease Clinical Trials | |||
Northera | Parkinson's Disease | |||
Desperate for Help Dandy-Walker with Orthostatic Headaches | Hydrocephalus | |||
Droxidopa / Study 302, a Phase III | Parkinson's Disease Clinical Trials | |||
Droxidopa / Study 302, a Phase III | Parkinson's Disease |